Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
The National Cancer Institute estimates that expenditures related to cancer care are likely to rise to $158 billion by 2020.1 Passage of the Affordable Care Act (ACA) has provoked a reorganization of the health care system and a drive to reduce costs. A number of organizations have proposed value frameworks and novel payment models. These include proposals from the American Society of Clinical Oncology2 and the Brookings Institute/MITRE Technical Expert Panel for Oncology.3 While the immediate focus is on cost reduction,2 the long-term goal is to incentivize a transition from transaction-based payment to a system that rewards value delivery.4
Alvarnas J, Majkowski GR, Levine AM. Moving Toward Economically Sustainable Value-Based Cancer Care in the Academic Setting. JAMA Oncol. 2015;1(9):1221–1222. doi:10.1001/jamaoncol.2015.3449
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: